Neovii logo
VerifiedBiotechnology· Founded 2003

Neovii

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.

7-day free trial · no credit card

Employees124(51 to 200)Founded year2003Websiteneovii.comLinkedIn profileLinkedIn

Verified contacts

101

available on Kipplo

LinkedIn employees

124

51 to 200 range

Open roles

no listings

Distinct roles

85

indexed titles

Tech stack

2

tools in use

Monthly traffic

18

organic / mo

Sign up free to see all 101 verified contacts at Neovii

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

101 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Neovii

85 distinct titles indexed · top 10 shown.

  • 3- ä ü
  • 3projektmanager
  • 3quality manager
  • 3rn
  • 2director medical affairs
  • 2it-systemadministrator
  • 2patient care technician
  • 2prozessingenieur
  • 2sales manager
  • 1()
  • +75more titles

Sign up to unlock all 101 contacts at Neovii

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 101 verified contacts at Neovii

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Neovii | Kipplo Discover